Fund shareholders of Mirum Pharmaceuticals Inc
ISIN US6047491013 · United States · LEI 254900YZKR40F7F27K81
- Fund shareholders
- 333
- Of which ETFs
- 53 280 other funds
- Value held
- 2B $ 259.7M SEK · 1.1M €
- Share of capital
- 33.3 % of 64.9M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Global Atlantic Wellington Research Managed Risk Portfolio Forethought Variable Insurance Trust | 586 | 54.1K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Longboard Fund NORTHERN LIGHTS FUND TRUST II | 582 | 53.7K $ | 0.05 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Victory Science & Technology Fund Victory Portfolios III | 507 | 49.3K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SIIT MULTI-ASSET REAL RETURN FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 500 | 46.1K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 476 | 46.3K $ | 0.08 % | 0.00 % | as of Apr 30, 2026 ↗ |
| MFS Global Alternative Strategy Fund MFS Series Trust XV | 464 | 45.2K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 461 | 42.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| JPMorgan Fundamental Data Science Small Core ETF J.P. Morgan Exchange-Traded Fund Trust | 418 | 38.6K $ | 0.52 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Stock K6 Fund Fidelity Concord Street Trust | 358 | 34.8K $ | 0.19 % | 0.00 % | as of Apr 30, 2026 ↗ |
| THRIVENT MODERATELY CONSERVATIVE ALLOCATION FUND Thrivent Mutual Funds | 344 | 33.5K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Victory Cornerstone Aggressive Fund Victory Portfolios III | 334 | 30.8K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 309 | 30.1K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 254 | 23.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 204 | 18.8K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 191 | 18.6K $ | 0.12 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 146 | 13.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SIMT Multi-Asset Inflation Managed Fund SEI INSTITUTIONAL MANAGED TRUST | 145 | 13.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 141 | 13K $ | 0.09 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SA Franklin Tactical Opportunities Portfolio SUNAMERICA SERIES TRUST | 132 | 12.8K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 120 | 11.7K $ | 0.15 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 107 | 9.9K $ | 0.08 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 94 | 8.7K $ | 0.07 % | 0.00 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Innovation Leaders ETF T. Rowe Price Exchange-Traded Funds, Inc. | 92 | 8.5K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 77 | 7.5K $ | 0.09 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 56 | 5.2K $ | 0.09 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 42 | 3.9K $ | 0.13 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 42 | 3.9K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 34 | 3.3K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 13 | 1.2K $ | 0.11 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 11 | 1K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 8 | 738.3 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 1M € | 1.22 % | as of Dec 31, 2025 ↗ | ||
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 80.7K € | 2.20 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| F/m Emerald Life Sciences Innovation ETF RBB Fund, Inc. | 4.84 % | as of Feb 28, 2026 ↗ |
| HealthInvest Small & Mid Cap Healthcare Atle Fund Management AB | 4.48 % | as of Mar 31, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 4.02 % | as of Mar 31, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 3.06 % | as of Feb 28, 2026 ↗ |
| Nomura Small Cap Growth Fund IVY FUNDS | 2.60 % | as of Mar 31, 2026 ↗ |
| SFT Nomura Small Cap Growth Fund Securian Funds Trust | 2.57 % | as of Mar 31, 2026 ↗ |
| Nomura VIP Small Cap Growth Series Ivy Variable Insurance Portfolios | 2.53 % | as of Mar 31, 2026 ↗ |
| Eventide Gilead Fund MUTUAL FUND SERIES TRUST | 2.44 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Etf ETFis Series Trust I | 2.39 % | as of Apr 30, 2026 ↗ |
| RiverPark/Next Century Growth Fund RiverPark Funds Trust | 2.22 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 326 | +37 | 21,314,975 | +14.4 % |
| 2026Q1 | 289 | +34 | 18,630,854 | +9.9 % |
| 2025Q4 | 255 | +31 | 16,959,488 | +0.4 % |
| 2025Q3 | 224 | +12 | 16,895,524 | +2.0 % |
| 2025Q2 | 212 | +28 | 16,566,922 | +5.1 % |
| 2025Q1 | 184 | +21 | 15,766,601 | -4.0 % |
| 2024Q4 | 163 | +18 | 16,426,299 | +11.0 % |
| 2024Q3 | 145 | -7 | 14,799,693 | +11.6 % |
| 2024Q2 | 152 | +3 | 13,261,526 | +17.0 % |
| 2024Q1 | 149 | +18 | 11,338,310 | +13.1 % |
| 2023Q4 | 131 | 10,025,489 |
Institutional managers
301 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 7,679,684 | 709.4M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 6,945,813 | 641.8M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 3,846,530 | 355.3M $ | as of Mar 31, 2026 |
| FMR LLC | 1,965,375 | 181.6M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 1,944,281 | 179.6M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1,717,421 | 158.7K $ | as of Mar 31, 2026 |
| BVF INC/IL | 1,584,727 | 146.4M $ | as of Mar 31, 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC | 1,408,871 | 130.1M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 1,334,809 | 123.3M $ | as of Mar 31, 2026 |
| NOVO HOLDINGS A/S | 1,325,000 | 122.4M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,260,003 | 116.4M $ | as of Mar 31, 2026 |
| TANG CAPITAL MANAGEMENT LLC | 1,236,027 | 114.2M $ | as of Mar 31, 2026 |
| TCG Crossover Management, LLC | 1,062,049 | 98.1M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 1,052,048 | 97.2M $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 911,419 | 84.2M $ | as of Mar 31, 2026 |
| Rock Springs Capital Management LP | 811,294 | 74.9M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 774,841 | 71.6M $ | as of Mar 31, 2026 |
| Capital World Investors | 724,415 | 66.9M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 722,177 | 66.7M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 714,804 | 66M $ | as of Mar 31, 2026 |
| Clearbridge Investments, LLC | 671,870 | 62.1M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 662,306 | 61.2M $ | as of Mar 31, 2026 |
| Paradigm Biocapital Advisors LP | 625,000 | 57.7M $ | as of Mar 31, 2026 |
| LORD, ABBETT & CO. LLC | 617,064 | 57K $ | as of Mar 31, 2026 |
| Bank of New York Mellon Corp | 584,523 | 54M $ | as of Mar 31, 2026 |
Declared shareholders of Mirum Pharmaceuticals Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| BlackRock, Inc. | 5.70 % | 3,465,559 | as of Mar 31, 2026 · SCHEDULE 13G |
Funds holding the debt of Mirum Pharmaceuticals Inc
19 funds declare 19 bond lines of this company. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
Cite this page
Titelia. "Fund shareholders of Mirum Pharmaceuticals Inc". https://titelia.com/en/stocks/mirum-pharmaceuticals-inc-US6047491013